Considerations and Contraindications in ERT:
Until recently, women with specific contraindications to estrogen replacement therapy have been unable to adequately address their menopausal symptoms. With the availability of a botanical source of Conjugated Phytoestrogen Complex in ProEstron, women
and their physicians may now have another option. Although each case needs to be considered by a physician, the following are some of the areas in which drug-based estrogen replacement is contraindicated:
There is no evidence of contraindication of these conditions with the use of ProEstron. Although some studies may indicate a potential benefit of phytoestrogens with some of these conditions, ProEstron is NOT considered to be in anyway a prevention or treatment for these conditions. Because each of these areas reflect serious medical conditions, regular and thorough monitoring by a physician is highly recommended.
- History or Presence of Sex Cell Related Cancers
- Irregular Bleeding
- Uterine Fibroids and Myomas
- Liver Dysfunction
- Gall Bladder Disease
- History of Stroke
- Fibrocystic Breast Disease
Long-term use of drug-based estrogen replacement is associated with a concurrent increased risk of side effects. This warrants the consideration of early ProEstron therapy, as well as simultaneous use of ProEstron with drug-based estrogens as a protective measure.